Emtricitabin og tenofovir, individuelt og i kombinationsbehandling, har udvist aktivitet mod HBV i farmakodynamiske undersøgelser (se pkt.
Emtricitabine and tenofovir individually and in combination have shown activity against HBV in pharmacodynamic studies (see section 5.1).